-
Je něco špatně v tomto záznamu ?
Siva-1 emerges as a tissue-specific oncogene beyond its classic role of a proapoptotic gene
J. Vachtenheim, R. Lischke, J. Vachtenheim,
Jazyk angličtina Země Nový Zéland
Typ dokumentu časopisecké články, přehledy
NLK
Free Medical Journals
od 2008
PubMed Central
od 2008
Europe PubMed Central
od 2008
ProQuest Central
od 2015-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Taylor & Francis Open Access
od 2008-12-01
Health & Medicine (ProQuest)
od 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
PubMed
30319276
DOI
10.2147/ott.s173001
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Siva-1 is a typical apoptotic protein commonly activated by the p53 tumor suppressor protein and should therefore participate in a barrier against the development of cancer. It has proapoptotic activities in various cell systems. Recent findings suggest that Siva-1 possesses several other apoptosis-independent functions and interacts with many other proteins not directly involved in apoptosis. It harbors the ARF E3 ubiquitin protein ligase activity, a property that is clearly prooncogenic and leads to p53 degradation through the upregulation of the Hdm2 protein level. Surprisingly, recent evidence shows that Siva-1 absence prevents the development of non-small cell lung carcinomas in a mouse model and reveals the oncogenic roles in the same types of human cells, indicating its unique function as an oncogene in the cell context-dependent manner. Herein, we review reported activities of Siva-1 in various experimental settings and comment on its ambiguous function in tumor biology.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19001644
- 003
- CZ-PrNML
- 005
- 20190115111115.0
- 007
- ta
- 008
- 190107s2018 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/OTT.S173001 $2 doi
- 035 __
- $a (PubMed)30319276
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Vachtenheim, Jiri $u Third Department of Surgery, First Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic.
- 245 10
- $a Siva-1 emerges as a tissue-specific oncogene beyond its classic role of a proapoptotic gene / $c J. Vachtenheim, R. Lischke, J. Vachtenheim,
- 520 9_
- $a Siva-1 is a typical apoptotic protein commonly activated by the p53 tumor suppressor protein and should therefore participate in a barrier against the development of cancer. It has proapoptotic activities in various cell systems. Recent findings suggest that Siva-1 possesses several other apoptosis-independent functions and interacts with many other proteins not directly involved in apoptosis. It harbors the ARF E3 ubiquitin protein ligase activity, a property that is clearly prooncogenic and leads to p53 degradation through the upregulation of the Hdm2 protein level. Surprisingly, recent evidence shows that Siva-1 absence prevents the development of non-small cell lung carcinomas in a mouse model and reveals the oncogenic roles in the same types of human cells, indicating its unique function as an oncogene in the cell context-dependent manner. Herein, we review reported activities of Siva-1 in various experimental settings and comment on its ambiguous function in tumor biology.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Lischke, Robert $u Third Department of Surgery, First Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic.
- 700 1_
- $a Vachtenheim, Jiri $u Department of Transcription and Cell Signaling, Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University Prague, Czech Republic, jiri.vachtenheim@lf1.cuni.cz.
- 773 0_
- $w MED00165461 $t OncoTargets and therapy $x 1178-6930 $g Roč. 11, č. - (2018), s. 6361-6367
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30319276 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190115111325 $b ABA008
- 999 __
- $a ind $b bmc $g 1365453 $s 1039767
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 11 $c - $d 6361-6367 $e 20181001 $i 1178-6930 $m OncoTargets and therapy $n OncoTargets ther. $x MED00165461
- LZP __
- $a Pubmed-20190107